<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8508183</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1289</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr. Neurol.</journal-id>
<journal-title-group>
<journal-title>Pediatric neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0887-8994</issn>
<issn pub-type="epub">1873-5150</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28844798</article-id>
<article-id pub-id-type="pmc">5610103</article-id>
<article-id pub-id-type="doi">10.1016/j.pediatrneurol.2017.06.010</article-id>
<article-id pub-id-type="manuscript">NIHMS902063</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis Complex</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Capal</surname>
<given-names>Jamie K</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horn</surname>
<given-names>Paul S.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Murray</surname>
<given-names>Donna S.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A8">h</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Byars</surname>
<given-names>Anna Weber</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bing</surname>
<given-names>Nicole M.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kent</surname>
<given-names>Bridget</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bucher</surname>
<given-names>Lindsey A.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Marian E.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Kelley</surname>
<given-names>Sarah</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pearson</surname>
<given-names>Deborah A.</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahin</surname>
<given-names>Mustafa</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krueger</surname>
<given-names>Darcy A.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mansour</surname>
<given-names>Rosleen</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hanson</surname>
<given-names>Ellen M.</given-names>
</name>
<xref ref-type="aff" rid="A7">g</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peters</surname>
<given-names>Jurriaan</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goyal</surname>
<given-names>Monisha</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walsh</surname>
<given-names>Amy</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bruns</surname>
<given-names>Stephanie</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Filip-Dhima</surname>
<given-names>Rajna</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mitchell</surname>
<given-names>Terry</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cutter</surname>
<given-names>Gary</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Northrup</surname>
<given-names>Hope</given-names>
</name>
<xref ref-type="aff" rid="A10">j</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Joyce Y.</given-names>
</name>
<xref ref-type="aff" rid="A9">i</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bebin</surname>
<given-names>Martina</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<on-behalf-of>ON BEHALF OF THE TACERN STUDY GROUP</on-behalf-of>
</contrib-group>
<aff id="A1">
<label>a</label>Department of Neurology MLC 2015, Cincinnati Children’s Hospital Medical Center 3333 Burnet Avenue, Cincinnati, OH, 45229, USA</aff>
<aff id="A2">
<label>b</label>Department of Developmental and Behavioral Pediatrics, Cincinnati Children’s Hospital Medical Center, 3430 Burnet Avenue, Cincinnati, OH, 45229, USA</aff>
<aff id="A3">
<label>c</label>Keck School of Medicine of USC, University of Southern California, Children’s Hospital Los Angeles, 4650 Sunset Blvd., MS#53, Los Angeles, CA 90027, USA</aff>
<aff id="A4">
<label>d</label>University of Alabama at Birmingham, 1720 2nd Ave S, Birmingham, AL 35233, USA</aff>
<aff id="A5">
<label>e</label>McGovern Medical School, The University of Texas Health Science Center at Houston, 1941 East Road, Rm. 3.126 BBSB; Houston, TX 77054</aff>
<aff id="A6">
<label>f</label>Department of Neurology, Boston Children’s Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA</aff>
<aff id="A7">
<label>g</label>Division of Developmental Medicine, Boston Children’s Hospital and Harvard Medical School, Boston, MA, 300 Longwood Avenue, 02115, USA</aff>
<aff id="A8">
<label>h</label>Autism Speaks Inc, 85 Devonshire St, Boston, MA 02109, USA</aff>
<aff id="A9">
<label>i</label>Division of Pediatric Neurology, UCLA Mattel Children’s Hospital, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095, USA</aff>
<aff id="A10">
<label>j</label>McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA</aff>
<author-notes>
<corresp id="FN1">Corresponding Author: Jamie K Capal, Department of Neurology, Cincinnati Children’s Hospital Medical Center, MLC 2015, 3333 Burnet Avenue, Cincinnati, OH 45229. Phone: 513-636-4222. Fax: 513-636- 1888. <email>Jamie.capal@cchmc.org</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>DISCLOSURE OF CONFLICTS OF INTEREST</p>
<p>JYW serves on the professional advisory board for the Tuberous Sclerosis Alliance; has received honoraria from and serves on the scientific advisory board and the speakers’ bureau for Novartis Pharmaceuticals Inc. and Lundbeck; and has received research support from the Tuberous Sclerosis Alliance, Novartis Pharmaceuticals Inc., Today’s and Tomorrow’s Children Fund, Department of Defense/Congressionally Directed Medical Research Program, and the NIH (U01NS082320, P20NS080199, R01NS082649, U54NS092090, and U01NS092595).</p>
<p>MS is supported by Developmental Synaptopathies Consortium (U54 NS092090), which is part of the NCATS Rare Diseases Clinical Research Network (RDCRN). His lab receives research funding from Roche, Novartis, Pfizer, and he has served on the Scientific Advisory Board of Sage Therapeutics. In addition, he serves on the Professional Advisory Board of the Tuberous Sclerosis Alliance and is an Associate Editor of Pediatric Neurology.</p>
<p>DAK has received consulting and speaking fees and travel expenses from Novartis and additional research support from the National Institute of Neurological Disorders and Stroke of the NIH (U01-NS082320, U54-NS092090, P20-NS080199), the Tuberous Sclerosis Alliance, the Van Andel Research Institute, Novartis, and Upsher-Smith Pharmaceuticals. In addition he serves on the professional advisory board and international relations committee for the Tuberous Sclerosis Alliance and the editorial board of Pediatric Neurology.</p>
<p>DAP has received research support from NIH (U01-NS082320; U54-NS092090; U01-NS092595); research support, consulting fees, and travel reimbursement from Curemark, LLC; and research support from Biomarin and Novartis.</p>
<p>HN currently has a project funded by BioMarin testing efficacy of an enzyme substitution drug for phenylketonuria (PKU).</p>
<p>The remaining authors have no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>75</volume>
<fpage>80</fpage>
<lpage>86</lpage>
<!--elocation-id from pubmed: 10.1016/j.pediatrneurol.2017.06.010-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P2">Tuberous Sclerosis Complex (TSC) is a genetic disorder with high prevalence of associated autism spectrum disorder (ASD). Primary objectives were to determine early predictors of autism risk to identify children with TSC in most need of early interventions. The Autism Observation Scale for Infants (AOSI) was evaluated as a measure of ASD-associated behaviors in infants with TSC at age 12 months and its ability to predict ASD at 24 months.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">Children ages 0 to 36 months with TSC were enrolled in the TSC Autism Center of Excellence Research Network (TACERN), a multicenter, prospective observational study to identify biomarkers of ASD. The AOSI was administered at age 12 months and the Autism Diagnostic Observation Schedule-2 (ADOS-2) and Autism Diagnostic Interview-Revised (ADI-R) at 24 months. Developmental functioning was assessed using the Mullen Scales of Early Learning. Children were classified as ASD or non-ASD according to the ADOS-2.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">Analysis included 79 children who had been administered the AOSI at 12 months and ADOS-2 and ADI-R at 24 months. The ASD group had a mean AOSI total score at 12 months significantly higher than the non-ASD group (11.8 ± 7.4 vs. 6.3 ± 4.7; p&lt;0.001). An AOSI total score cut-off of 13 provided a specificity of 0.89 to detect ASD with the ADOS-2. AOSI total score at 12 months was similarly associated with exceeding cut-off scores on the ADI-R.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P5">The AOSI is a useful clinical tool in determining which infants with TSC are at increased risk for developing ASD.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Tuberous Sclerosis Complex</kwd>
<kwd>autism spectrum disorder</kwd>
<kwd>Autism Observational Scale for Infants</kwd>
<kwd>Autism Diagnostic Observation Schedule</kwd>
<kwd>infants</kwd>
<kwd>toddlers</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>